Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ruiqun Chen"'
Autor:
Wenna Chi, Na Kang, Linlin Sheng, Sichen Liu, Lei Tao, Xizhi Cao, Ye Liu, Can Zhu, Yuming Zhang, Bolong Wu, Ruiqun Chen, Lili Cheng, Jing Wang, Xiaolin Sun, Xiaohui Liu, Haiteng Deng, Jinliang Yang, Zhanguo Li, Wanli Liu, Ligong Chen
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract Monocarboxylate transporter 1 (MCT1) exhibits essential roles in cellular metabolism and energy supply. Although MCT1 is highly expressed in activated B cells, it is not clear how MCT1-governed monocarboxylates transportation is functionally
Externí odkaz:
https://doaj.org/article/10e9f4721f194dc9bfab77aea9e92eec
Autor:
Lili Cheng, Deepak, N. V. Krishna, Guoqiang Wang, Ziyi Meng, Lei Tao, Mengqing Xie, Wenna Chi, Yuming Zhang, Mingming Yang, Yilie Liao, Ruiqun Chen, Yu Liang, Junyu Zhang, Yuedong Huang, Weihua Wang, Zhiying Guo, Yunfang Wang, Lin, Jiandie D., Hao Fan, Ligong Chen
Publikováno v:
Hepatology (02709139); Dec2023, Vol. 78 Issue 6, p1828-1842, 15p
Autor:
Ruiqun Chen, Ligong Chen
Publikováno v:
Trends in Cell Biology. 32:186-201
Solute carrier transporters (SLCs) mediate nutrient and metabolite cellular homeostasis. Immune cells depend on SLCs to induce rapid and robust metabolic reprogramming, thereby controlling diverse immunological responses. Recent studies hint toward a
Autor:
Lili Cheng, R.N.V. Krishna Deepak, Guoqiang Wang, Ziyi Meng, Lei Tao, Mengqing Xie, Wenna Chi, Yuming Zhang, Mingming Yang, Yilie Liao, Ruiqun Chen, Yu Liang, Junyu Zhang, Yuedong Huang, Weihua Wang, Zhiying Guo, Yunfang Wang, Jiandie D. Lin, Hao Fan, Ligong Chen
Publikováno v:
Hepatology.
Publikováno v:
RSC Advances. 8:27448-27463
In our study, systems pharmacology was used to predict the molecular targets of Astragalus and Leech, and explore the therapeutic mechanism of type 2 diabetic nephropathy (T2DN) treated with Astragalus and Leech. Simultaneously, to reveal the systemi
Publikováno v:
RSC Advances. 8:1098-1115
In this study, systems pharmacology was used to predict the molecular targets of You-gui pill (YGP) and explore the therapeutic mechanism of Kidney-Yang Deficiency Syndrome (KYDS) treated with YGP. On the basis of this, serum samples from control gro
Publikováno v:
RSC Advances. 7:34251-34261
The central aim of this study was to investigate metabolite changes in metabolic pathways via metabonomic approaches in rats suffering from Kidney-Yang Deficiency Syndrome (KYDS) induced by hydrocortisone. Metabonomic analysis using 1H NMR is a well-
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 15, p 3655 (2019)
International Journal of Molecular Sciences
Volume 20
Issue 15
International Journal of Molecular Sciences
Volume 20
Issue 15
Kidney-yang deficiency syndrome (KYDS) is a metabolic disease caused by a neuro-endocrine disorder. The You-gui pill (YGP) is a classic traditional Chinese medicine (TCM) formula for the treatment of KYDS and has been widely used to warm and recupera
Publikováno v:
Journal of ethnopharmacology. 244
Ethnopharmacological relevance A myriad of evidence have shown that kidney-yang deficiency syndrome (KYDS) is associated with metabolic disorders of the intestinal microbiota, while TCMs can treat KYDS by regulating gut microbiota metabolism. However
Publikováno v:
RSC advances. 8(48)
In our study, systems pharmacology was used to predict the molecular targets of